Tag: Dr Reddy’s Laboratories
Novartis India extends access to its medicines in India by signing...
The arrangement brings together the manufacturing and development synergies of Novartis India Limited with the sales and distribution strengths of Dr. Reddy’s Laboratories
Pharma industry reiterates its commitment to US$ 130 billon by 2030
Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance
Top 5 pharma majors collaborate to conduct clinical trial of anti-viral...
Cipla, Dr. Reddy’s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19...........................
Sputnik V launched in India, imported doses to cost INR 995
Russia's Sputnik V vaccine has become the first foreign-made vaccine that is used in India contributing to the world’s largest COVID-19 vaccination campaign................
Dr Reddy’s Lab registers 3% decline in net profit
The consolidated net profit of the Reddy's Laboratories for the fourth quarter ending 31st March stood at Rs 302.2 crore............
Dr Reddy’s reaches a $ 5 million settlement with the US...
The company has said that while it firmly disagrees with the United States government’s allegations, it wanted to avoid any unnecessary costs and the distractions of prolonged litigation............
Dr Reddy’s Labs launches generic Azacitidine for injection in the Canadian...
As per Dr Reddy’s Laboratories, this launch represents its commitment to make affordable injectable drugs available in Canada............
Dr Reddy’s Labs out-licenses its psoriasis drug to Encore Dermatology
DFD-06, a topical high potency steroid is being commercialized in the United States market by Promius Pharma, LLC, the fully owned subsidiary of Dr Reddy's Lab..........
Dr Reddy’s Labs announces the commercialization of Vozet in India
The anti-histamine tablet is used for the treatment of symptoms of allergic conditions in humans and has a huge market in India........
Dr Reddy’s Laboratories gets USFDA’s EIR to API plant in Telangana
The US Food and Drug Administration has given an 'establishment inspection report' to the company after inspection of Dr Reddy Laboratories active pharmaceutical ingredients (API) unit at Miryalaguda in Telangana.........